Employee Benefits News examines legal developments that impact the employee benefits and executive compensation employers provide, including federal and state legislation, rules from federal...
Dec. 9 — Accusations of a prescription drug overcharging scheme involving some of the country’s largest pharmacy benefit managers and health insurers have spawned 10 proposed class actions in the past two months.
Taken together, the lawsuits claim that PBMs OptumRx and Humana Pharmacy Solutions Inc. worked with health insurers to overcharge patients for prescription drugs. The most recent complaints were filed on Dec. 7 and Dec. 8 against Cigna and UnitedHealth, respectively. According to the lawsuits, when a given prescription drug costs less than a patient’s copayment amount, insurers including United Healthcare, Cigna and Humana “claw back” the difference through an improper scheme kept hidden from patients ( Davis v. OptumRx, Inc. , C.D. Cal., No. 8:16-cv-02165, complaint filed 12/7/16 ; Mastra v. UnitedHealth Grp., Inc. , D. Minn., No. 0:16-cv-04119, complaint filed 12/8/16 ).
Since Oct. 4, at least 10 lawsuits have been filed challenging this alleged scheme. The recent complaint against UnitedHealth claims that “tens of thousands” of people have been affected, while the Cigna lawsuit places the number in the “hundreds of thousands.”
Many of the lawsuits cite an investigation into health insurance clawbacks that New Orleans television station Fox 8 began airing in May. The investigation found that some insured patients may be paying more for prescription drugs than they would if they lacked insurance altogether.
The Dec. 7 lawsuit against Cigna and OptumRx was filed by Whatley Kallas LLP, Steel Wright Gray & Hutchinson PLLC and Mauriello Law Firm. This legal team also filed a lawsuit against OptumRX and UnitedHealth on Nov. 23.
The Dec. 8 suit against UnitedHealth was filed by Gustafson Gluek.
A representative for Cigna declined to comment on the lawsuit against it. UnitedHealth representatives didn’t immediately respond to requests for comment.
To contact the reporter on this story: Jacklyn Wille in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Jo-el J. Meyer at email@example.com
Text of the complaint against Cigna and OptumRx is at http://www.bloomberglaw.com/public/document/Davis_v_Optumrx_Inc_et_al_Docket_No_816cv02165_CD_Cal_Dec_07_2016/1. Text of the complaint against UnitedHealth is at http://www.bloomberglaw.com/public/document/Mastra_v_UnitedHealth_Group_Inc_et_al_Docket_No_016cv04119_D_Minn.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)